Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Education » International Journal of Cancer Publication

International Journal of Cancer Publication

  • November 25, 2019

Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals, published in the International Journal of Cancer.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs).

The findings of this survey provide a more detailed picture of the unmet needs of NET patients than identified previously in the literature and highlights key areas for improvement. To our knowledge, this is the first international study that has compared perceptions of patients’ unmet needs from the differing perspectives of patients/families, advocates and HCPs. Several important unmet needs were identified. In each of the areas surveyed, less than a quarter of patients felt their needs for more information at diagnosis were fully met. While HCPs generally agreed that there is room for improvement, overall they were considerably more confident about their ability to meet patients’ needs than reflected by the experiences of patients themselves.

The authors identified the following action points which should be addressed urgently:       

– Improve utilization of exisiting resources, such as including patients in MDTs and providing written information to patients at time of consultation.

– Educate HCPs to enable them to provide patients with sufficient information at diagnosis and about treatment options

– Provide information and resources to keep patient organisation websites up-to-date as these are an important source of information

– Facilitate access to main diagnostic tools and treatments such as Gallium-68-Dotatate PET/CT scan and PRRT

– Provide financial help for patients in need and improve access to caregivers

– Improve access to MDTs

– Encourage nurses to specialise in NETs, and ensure training involves teaching around psychological care

– Increase patient involvement in research by providing information about ongoing trials and facilitate access

We are very proud of the hard work that was put into this publication and we will use these findings to raise awareness and encourage change for all NET Patients. To read the full article please click here.

Share this post

Recent posts

Radio National Interview: Changing Australia June 2025

June 30, 2025

Adelaide NET Patient Forum 2025

June 24, 2025

CNSA & ICCN 2025 Congress: Global Voices, Local Actions

June 24, 2025

Announcing our First Patient Ambassador – Cassie Miller

June 17, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousAre you eligible for a clinical trial?
NextClinical Trials and Neuroendocrine TumoursNext

Related Posts

Radio National Interview: Changing Australia June 2025

Rare cancers can be extremely difficult to diagnose, and it can take years of misdiagnoses before a culprit is found and patients get adequate treatment.

Adelaide NET Patient Forum 2025

Pictured – DR Ria Joseph, Dr Chad Han, A/Prof Gabby Cehic, Meredith Cummins, Dr Rebekah Chew, Jessica Mercurio and Dr Rahul Solanki Thank you to

CNSA & ICCN 2025 Congress: Global Voices, Local Actions

NECA proudly attended the CNSA & ICCN 2025 Annual Congress, held at the Adelaide Convention Centre from 18–21 June 2025. This landmark event was a

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

NeuroEndocrine Cancer Australia (NECA) was proud to attend the 5th Neuroendocrine Tumour (NET) Preceptorship held 13 & 14th June at Peter MacCallum Cancer Centre in

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin